reSee.it Video Transcript AI Summary
Speaker 0 reports that hundreds of women across the US and UK are banding together to sue Pfizer over the Depo Provera birth control injection, alleging a link to brain tumor development. The lawsuits reference a French study from the previous year showing that women who received the birth control injection and used Depo Provera for more than a year were five times more likely to develop a meningioma, a specific type of brain tumor. The study is said to be robust, noting that eighteen thousand women in the study between 2009 and 2018 underwent brain surgery specifically for meningioma.
The speaker emphasizes the scope of Depo Provera’s use, stating that more than forty million women have already used the injectable birth control. A 2021 publication in the Journal of Family Medicine and Primary Care is cited, reporting that over forty-two million women were using injectable birth controls like Depo Provera. In the United States, this represents about twenty-five percent, or one quarter, of all sexually active women.
The discussion places the current litigation in the context of earlier legal actions concerning hormonal birth control. The speaker notes that this is not the first class-action lawsuit about birth control companies not adequately warning users about potential health impacts. A 2014 settlement is recalled, where a pharmaceutical company agreed to a global settlement of $100,000,000 over NuvaRing-related issues, specifically blood clotting problems leading to deep vein thrombosis, stroke, or death.
The speaker then shifts attention to other birth control options, pointing to Nexplanon, an implant placed in the arm, and remarks that videos or attention around Nexplanon suggest that a similar class action could be anticipated in the future. The overall sentiment conveyed is that there is growing public concern and scrutiny of hormonal birth control products and their health risks.
Finally, the speaker notes that mainstream media and companies are questioning why women are quitting birth control, implying a broader trend of declining use in response to safety concerns and lawsuits.